• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

棘突融合蛋白和 retronectin 可显著提高人源原发性 T 细胞中 Mucin-1 特异性嵌合抗原受体 (CAR) 的基因转导效率。

Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells.

机构信息

Department of Applied Cell Sciences, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.

Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

BMC Mol Cell Biol. 2021 Nov 23;22(1):57. doi: 10.1186/s12860-021-00397-z.

DOI:10.1186/s12860-021-00397-z
PMID:34814824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8609792/
Abstract

BACKGROUND

Producing an appropriate number of engineered cells is considered as one of the influential factors in the successful treatments with chimeric antigen receptor (CAR) T cells. To this aim, the transduction rate of the viral vectors can play a significant role. In addition, improving transduction rates can affect the success rate of this treatment due to hard-transduced T lymphocytes.

RESULTS

In this study, activated T cells were transduced using different transduction methods such as spinoculation, retronectin, polybrene, spinoculation + retronectin, and spinoculation + polybrene after selecting the most efficient transfection method to produce recombinant viral particles containing MUC1 CAR. PEI and lipofectamine with the amount of 73.72 and 72.53%, respectively, showed the highest transfection rates with respect to calcium phosphate (14.13%) for producing lentiviral particles. However, the cytotoxicity of transfection methods was not significantly different. Based on the results, spinoculation + retronectin leads to the highest transduction rates of T cells (63.19 ± 4.45%) relative to spinoculation + polybrene (34.6 ± 4.44%), polybrene (10.23 ± 0.79%), retronectin (10.37 ± 1.85%), and spinoculation (21.11 ± 1.55%). Further, the polybrene (40.02%) and spinoculation + polybrene (48.83% ± 4.83) increased cytotoxicity significantly compared to other groups.

CONCLUSION

Improving transduction conditions such as using spinoculation with retronectin can ameliorate the production of CAR-T cells by increasing the rate of transduction, as well as the success rate of treatment.

摘要

背景

产生适当数量的工程细胞被认为是嵌合抗原受体 (CAR) T 细胞成功治疗的影响因素之一。为此,病毒载体的转导率可以发挥重要作用。此外,由于硬转导的 T 淋巴细胞,提高转导率会影响这种治疗的成功率。

结果

在这项研究中,使用不同的转导方法(如旋转感染、转铁蛋白、聚凝胺、旋转感染+转铁蛋白和旋转感染+聚凝胺)转导激活的 T 细胞,然后选择最有效的转染方法来产生含有 MUC1 CAR 的重组病毒颗粒。PEI 和 lipofectamine 的转染效率分别为 73.72%和 72.53%,相对于磷酸钙(14.13%)而言,产生的慢病毒颗粒最高。然而,转染方法的细胞毒性没有显著差异。基于这些结果,旋转感染+转铁蛋白导致 T 细胞的转导率最高(63.19±4.45%),相对于旋转感染+聚凝胺(34.6±4.44%)、聚凝胺(10.23±0.79%)、转铁蛋白(10.37±1.85%)和旋转感染(21.11±1.55%)。此外,聚凝胺(40.02%)和旋转感染+聚凝胺(48.83%±4.83%)与其他组相比,细胞毒性显著增加。

结论

改善转导条件,如使用旋转感染和转铁蛋白,可以通过提高转导率和治疗成功率来改善 CAR-T 细胞的产生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/9a5f5e58542b/12860_2021_397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/d3b800b0d5bd/12860_2021_397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/390d826da2b3/12860_2021_397_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/d52b17635726/12860_2021_397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/9a5f5e58542b/12860_2021_397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/d3b800b0d5bd/12860_2021_397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/390d826da2b3/12860_2021_397_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/d52b17635726/12860_2021_397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83dd/8609792/9a5f5e58542b/12860_2021_397_Fig4_HTML.jpg

相似文献

1
Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells.棘突融合蛋白和 retronectin 可显著提高人源原发性 T 细胞中 Mucin-1 特异性嵌合抗原受体 (CAR) 的基因转导效率。
BMC Mol Cell Biol. 2021 Nov 23;22(1):57. doi: 10.1186/s12860-021-00397-z.
2
Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation.多聚凝胺和纤连蛋白作为转导增强剂对基于VHH的CD19重定向嵌合抗原受体T细胞发育及表型特征的影响:一项对比研究
Clin Exp Med. 2023 Oct;23(6):2535-2549. doi: 10.1007/s10238-022-00928-8. Epub 2022 Nov 25.
3
High efficiency closed-system gene transfer using automated spinoculation.利用自动化旋转接种技术实现高效封闭式基因转移。
J Transl Med. 2021 Nov 24;19(1):474. doi: 10.1186/s12967-021-03126-4.
4
Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells.转铁蛋白介导的 T 细胞激活对 CD19 特异性嵌合抗原受体 T 细胞扩增和表型的影响。
Hum Gene Ther. 2018 Oct;29(10):1167-1182. doi: 10.1089/hum.2017.237. Epub 2018 Sep 5.
5
Fabrication and Use of Dry Macroporous Alginate Scaffolds for Viral Transduction of T Cells.制备和使用干大孔海藻酸钠支架进行 T 细胞的病毒转导。
J Vis Exp. 2022 Sep 9(187). doi: 10.3791/64036.
6
Scaffold-Mediated Static Transduction of T Cells for CAR-T Cell Therapy.支架介导的 T 细胞静态转导用于 CAR-T 细胞治疗。
Adv Healthc Mater. 2020 Jul;9(14):e2000275. doi: 10.1002/adhm.202000275. Epub 2020 Jun 11.
7
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cells.用于生产和扩增抗 CD19 嵌合抗原受体 T 细胞的媒介评估。
Cytotherapy. 2018 Jul;20(7):941-951. doi: 10.1016/j.jcyt.2018.04.007. Epub 2018 May 30.
8
Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application.用于临床应用的γ逆转录病毒基因导入人T淋巴细胞的多因素优化
Hum Gene Ther. 2007 Dec;18(12):1253-60. doi: 10.1089/hum.2007.088.
9
Generation of CAR-T Cells by Lentiviral Transduction.慢病毒转导 CAR-T 细胞的生成。
Methods Mol Biol. 2021;2312:3-14. doi: 10.1007/978-1-0716-1441-9_1.
10
Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.不同的细胞因子和刺激条件会影响针对肿瘤抗原GD2的第三代嵌合抗原受体T细胞的扩增和免疫表型。
Cytotherapy. 2015 Apr;17(4):487-95. doi: 10.1016/j.jcyt.2014.12.002. Epub 2015 Jan 6.

引用本文的文献

1
Developing drug-like single-domain antibodies (VHH) from in vitro libraries.从体外文库开发类药物单域抗体(VHH)
MAbs. 2025 Dec;17(1):2516676. doi: 10.1080/19420862.2025.2516676. Epub 2025 Jun 25.
2
Transduction of γδ T cells with Baboon envelope pseudotyped lentiviral vector encoding chimeric antigen receptors for translational and clinical applications.用编码嵌合抗原受体的狒狒包膜假型慢病毒载体转导γδ T细胞,用于转化研究和临床应用。
Front Immunol. 2025 Jun 6;16:1548630. doi: 10.3389/fimmu.2025.1548630. eCollection 2025.
3
Optimizing viral transduction in immune cell therapy manufacturing: key process design considerations.

本文引用的文献

1
Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells.用于静息免疫细胞中高效转基因表达的模块化慢病毒载体。
Viruses. 2021 Jun 18;13(6):1170. doi: 10.3390/v13061170.
2
Current Progress in CAR-T Cell Therapy for Hematological Malignancies.嵌合抗原受体T细胞(CAR-T)疗法治疗血液系统恶性肿瘤的当前进展
J Cancer. 2021 Jan 1;12(2):326-334. doi: 10.7150/jca.48976. eCollection 2021.
3
Mechanisms underlying CD19-positive ALL relapse after anti-CD19 CAR T cell therapy and associated strategies.抗CD19嵌合抗原受体T细胞疗法后CD19阳性急性淋巴细胞白血病复发的潜在机制及相关策略。
优化免疫细胞治疗生产中的病毒转导:关键工艺设计考量
J Transl Med. 2025 May 2;23(1):501. doi: 10.1186/s12967-025-06524-0.
4
Enhancing the Efficacy of CAR-T Cell Production Using BX795 and Rosuvastatin in a Serum-Free Medium.在无血清培养基中使用BX795和瑞舒伐他汀提高CAR-T细胞生产效率
Int J Mol Sci. 2025 Mar 25;26(7):2988. doi: 10.3390/ijms26072988.
5
Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy.白细胞去除滤器来源的自然杀伤细胞为现成的嵌合抗原受体自然杀伤细胞免疫疗法提供了一个有前景的来源。
Sci Rep. 2025 Apr 14;15(1):12755. doi: 10.1038/s41598-025-97584-1.
6
Protocol for the simultaneous activation and lentiviral transduction of primary human T cells with artificial T cell receptors.用人造T细胞受体同时激活和慢病毒转导原代人T细胞的方案
STAR Protoc. 2025 Mar 21;6(1):103685. doi: 10.1016/j.xpro.2025.103685. Epub 2025 Mar 10.
7
Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins.利用基于 HIV 的假病毒平台对泛冠状病毒刺突蛋白进行细胞转导的优化。
Viruses. 2024 Sep 20;16(9):1492. doi: 10.3390/v16091492.
8
Methodological Approaches for Increasing the Retroviral Transduction Efficiency of Primary NK Cells.提高原代自然杀伤细胞逆转录病毒转导效率的方法学途径。
Curr Pharm Des. 2024;30(37):2947-2958. doi: 10.2174/0113816128314633240724060916.
9
Implantable CAR T cell factories enhance solid tumor treatment.可植入 CAR T 细胞工厂增强实体瘤治疗。
Biomaterials. 2024 Jul;308:122580. doi: 10.1016/j.biomaterials.2024.122580. Epub 2024 Apr 15.
10
Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies.靶向自噬可克服 B 细胞恶性肿瘤中 CAR-T 免疫疗法的内在耐药性。
Cancer Commun (Lond). 2024 Mar;44(3):408-432. doi: 10.1002/cac2.12525. Epub 2024 Feb 26.
Biomark Res. 2020 May 27;8:18. doi: 10.1186/s40364-020-00197-1. eCollection 2020.
4
Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy.优化慢病毒载体生产和转导方法以促进免疫治疗和基因治疗的简要综述。
Biomed Pharmacother. 2020 Aug;128:110276. doi: 10.1016/j.biopha.2020.110276. Epub 2020 Jun 2.
5
Process for an efficient lentiviral cell transduction.高效慢病毒细胞转导的方法。
Biol Methods Protoc. 2020 Feb 10;5(1):bpaa005. doi: 10.1093/biomethods/bpaa005. eCollection 2020.
6
A VHH-Based Anti-MUC1 Chimeric Antigen Receptor for Specific Retargeting of Human Primary T Cells to MUC1-Positive Cancer Cells.一种基于VHH的抗MUC1嵌合抗原受体,用于将人原代T细胞特异性重定向至MUC1阳性癌细胞。
Cell J. 2021 Jan;22(4):502-513. doi: 10.22074/cellj.2021.6917. Epub 2020 Apr 22.
7
Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions.利用 CAR 为基础的免疫疗法靶向 T 细胞恶性肿瘤:挑战与潜在解决方案。
J Hematol Oncol. 2019 Dec 29;12(1):141. doi: 10.1186/s13045-019-0801-y.
8
Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospects.GMP 级慢病毒载体生产 CAR T 细胞:最新进展和未来前景。
Crit Rev Clin Lab Sci. 2019 Sep;56(6):393-419. doi: 10.1080/10408363.2019.1633512. Epub 2019 Jul 17.
9
HIV-1 Nef Disrupts CD4 T Lymphocyte Polarity, Extravasation, and Homing to Lymph Nodes via Its Nef-Associated Kinase Complex Interface.HIV-1 Nef 通过其 Nef 相关激酶复合物界面破坏 CD4 T 淋巴细胞的极性、外渗和归巢到淋巴结。
J Immunol. 2018 Nov 1;201(9):2731-2743. doi: 10.4049/jimmunol.1701420. Epub 2018 Sep 26.
10
Virus-Receptor Interactions: The Key to Cellular Invasion.病毒-受体相互作用:细胞入侵的关键。
J Mol Biol. 2018 Aug 17;430(17):2590-2611. doi: 10.1016/j.jmb.2018.06.024. Epub 2018 Jun 18.